Educational Supporters

The Omega-3 tale: where do we stand?

This activity has been supported by an educational grant from Amarin.


New approaches to LDL lowering

This activity has been supported by an educational grant from Esperion.


PCSK9 inhibition: new insights from clinical trials

This activity has been supported by an educational grant from Sanofi-Regeneron.


Moving from high-intensity statin therapy to high-intensity lipid lowering therapy. Is it time to reconsider the guidelines?

This activity has been supported by an educational grant from Mylan.


Problems and solutions in lipid lowering therapy: how to optimise dyslipidaemia management

This activity has been supported by an educational grant from Sanofi gem.


How can we improve outcomes in our patients with CAD?

This activity has been supported by an educational grant from MSD.